SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-007807
Filing Date
2024-02-29
Accepted
2024-02-29 08:04:33
Documents
17
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcel-20240229.htm   iXBRL 8-K 33280
2 EX-99.1 ex991earningsreleaseq42023.htm EX-99.1 146495
6 vericellogoa23.jpg GRAPHIC 48734
  Complete submission text file 0001628280-24-007807.txt   393130

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20240229.xsd EX-101.SCH 2523
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20240229_lab.xml EX-101.LAB 24453
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20240229_pre.xml EX-101.PRE 13056
18 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20240229_htm.xml XML 2697
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 24698973
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)